An explosion of new and innovative biologic drugs has improved the quality of life for patients suffering from a wide array of chronic illnesses.
The breakthrough treatments for autoimmune conditions such as Crohn's disease are a blessing for patients, a boon to society, and a benefit for businesses now able to tap into a pool of talented individuals whose illness-related disabilities would have presented severe workplace challenges just a generation ago.